Unknown

Dataset Information

0

Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.


ABSTRACT:

Background

Multiple studies have reported brain lipidomic abnormalities in Alzheimer's disease (AD) that affect glycerophospholipids, sphingolipids, and fatty acids. However, there is no consensus regarding the nature of these abnormalities, and it is unclear if they relate to disease progression.

Objective

Monogalactosyl diglycerides (MGDGs) are a class of lipids which have been recently detected in the human brain. We sought to measure their levels in postmortem human brain and determine if these levels correlate with the progression of the AD-related traits.

Methods

We measured MGDGs by ultrahigh performance liquid chromatography tandem mass spectrometry in postmortem dorsolateral prefrontal cortex gray matter and subcortical corona radiata white matter samples derived from three cohorts of participants: the Framingham Heart Study, the Boston University Alzheimer's Disease Research Center, and the Arizona Study of Aging and Neurodegenerative Disorders/Brain and Body Donation Program (total n = 288).

Results

We detected 40 molecular species of MGDGs (including diacyl and alkyl/acyl compounds) and found that the levels of 29 of them, as well as total MGDG levels, are positively associated with AD-related traits including pathologically confirmed AD diagnosis, clinical dementia rating, Braak and Braak stage, neuritic plaque score, phospho-Tau AT8 immunostaining density, levels of phospho-Tau396 and levels of Aβ40. Increased MGDG levels were present in both gray and white matter, indicating that they are widespread and likely associated with myelin-producing oligodendrocytes-the principal cell type of white matter.

Conclusions

Our data implicate the MGDG metabolic defect as a central correlate of clinical and pathological progression in AD.

SUBMITTER: Blusztajn JK 

PROVIDER: S-EPMC10911245 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.

Blusztajn Jan Krzysztof JK   Aytan Nurgul N   Rajendiran Thekkelnaycke T   Mellott Tiffany J TJ   Soni Tanu T   Burant Charles F CF   Serrano Geidy E GE   Beach Thomas G TG   Lin Honghuang H   Stein Thor D TD  

Journal of Alzheimer's disease : JAD 20230101 4


<h4>Background</h4>Multiple studies have reported brain lipidomic abnormalities in Alzheimer's disease (AD) that affect glycerophospholipids, sphingolipids, and fatty acids. However, there is no consensus regarding the nature of these abnormalities, and it is unclear if they relate to disease progression.<h4>Objective</h4>Monogalactosyl diglycerides (MGDGs) are a class of lipids which have been recently detected in the human brain. We sought to measure their levels in postmortem human brain and  ...[more]

Similar Datasets

| S-EPMC10117777 | biostudies-literature
| S-EPMC5801003 | biostudies-literature
| S-EPMC5373775 | biostudies-literature
| S-EPMC10755914 | biostudies-literature
| S-EPMC9617002 | biostudies-literature
| S-EPMC3073518 | biostudies-literature
| S-EPMC9830315 | biostudies-literature
| S-EPMC10529741 | biostudies-literature
| S-EPMC5573310 | biostudies-literature
| S-EPMC4098858 | biostudies-literature